262 results
Page 5 of 14
PRE 14A
i0mse
11 Mar 19
Preliminary proxy
5:07pm
8-K
EX-99.1
o0c3kr
7 Feb 19
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
EX-99.1
ysxvy69jha
15 Jan 19
Entry into a Material Definitive Agreement
5:19pm
424B5
gayqbelfobe10
15 Jan 19
Prospectus supplement for primary offering
5:14pm
424B5
4v6selprkye
14 Jan 19
Prospectus supplement for primary offering
4:41pm
8-K
EX-99.1
lqks1s0seigz3
7 Jan 19
Results of Operations and Financial Condition
8:11am
8-K
EX-99.1
3maeovr70k54s
7 Nov 18
Alnylam Pharmaceuticals Reports Third Quarter 2018 Financial Results and Highlights Recent Period Activity
8:16am
8-K
EX-99.1
2c7e9f zr3
10 Aug 18
ONPATTROâ„¢ (patisiran) for the Treatment of the Polyneuropathy of Hereditary
3:45pm
8-K
EX-99.1
uaghp7ysb5yuhpf9vi
2 Aug 18
Alnylam Pharmaceuticals Reports Second Quarter 2018 Financial Results and Highlights Recent Period Activity
8:15am
8-K
EX-99.1
gw8msih
3 May 18
Alnylam Pharmaceuticals Reports First Quarter 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
EX-99.1
oo6xrqi hayuc
20 Apr 18
Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade
12:00am